Hormonal, Psychological, and Alcohol Craving Changes after m-Chlorophenylpiperazine Administration in Alcoholics

To assess the serotonergic function of alcoholics, their neuroendocrine and psychological responsivities to the serotonergic partial agonist meta‐chlorophenylpiperazine (m‐CPP) was compared with the responsitivity of healthy subjects. The effect of m‐CPP on craving for alcohol was also assessed in t...

Full description

Saved in:
Bibliographic Details
Published inAlcoholism, clinical and experimental research Vol. 21; no. 2; pp. 220 - 227
Main Authors Buydens-Branchey, L., Branchey, M., Fergeson, P., Hudson, J., McKernin, C.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.04.1997
Lippincott Williams & Wilkins
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To assess the serotonergic function of alcoholics, their neuroendocrine and psychological responsivities to the serotonergic partial agonist meta‐chlorophenylpiperazine (m‐CPP) was compared with the responsitivity of healthy subjects. The effect of m‐CPP on craving for alcohol was also assessed in the alcoholics. Sixteen patients and 14 controls were tested under double‐blind, placebo‐controlled conditions. m‐CPP (0.5 mg/kg of body weight) was given orally. Alcoholics were tested after a period of abstinence of 15 to 39 days. The two groups of subjects did not differ in their cortisol response to m‐CPP, but the prolactin response of alcoholics was significantly blunted. Alcoholics reported a significantly more intense “high” feeling after m‐CPP than the healthy subjects. m‐CPP induced also a decreased craving for alcohol. Our data thus provide further evidence for the existence of a serotonergic dysfunction in alcoholics and a modulation of craving for alcohol by serotonergic systems.
Bibliography:ArticleID:ACER220
ark:/67375/WNG-4GC6HVBK-J
istex:1F25C90E809AEB5DD96BA20CF6A0D18D6856109E
This study was supported by a Merit Review Grant from the Department of Veterans Affairs.
ISSN:0145-6008
1530-0277
DOI:10.1111/j.1530-0277.1997.tb03753.x